Alexion Pharmaceuticals
Audrey Cohen is an experienced regulatory affairs professional with a strong background in the pharmaceutical and biotechnology sectors. Currently serving as Associate Director of Regulatory Development Strategy at Alexion Pharmaceuticals, Inc. since January 2021, Audrey has previously held positions such as Regulatory Affairs Manager and Senior Regulatory Affairs Specialist. Prior experience includes roles at Vertex Pharmaceuticals, Genentech, and bluebird bio, where responsibilities encompassed regulatory strategy development, application submissions to health authorities, and cross-functional team leadership. Audrey's educational qualifications include a Doctor of Pharmacy (PharmD) and a Master of Science from Paris-Sud University and a Baccalauréat in Science from Lycée Jean-Baptiste Say.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.